Ergoteles LLC Global Blood Therapeutics, Inc. Transaction History

Ergoteles LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$32.4 - $68.18 $2.84 Million - $5.97 Million	87,544 Added 1031.99%	96,027 $6.54 Million
Q2 2022 Aug 12, 2022	BUY	$22.3 - $37.39 $189,170 - $317,179	8,483 New	8,483 $271,000
Q1 2022 May 13, 2022	SELL	$25.68 - $35.59 $237,873 - $329,670	-9,263 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$24.9 - $40.26 $230,648 - $372,928	9,263 New	9,263 $271,000
Q2 2021 Aug 12, 2021	SELL	$32.46 - $43.42 $2.97 Million - $3.97 Million	-91,449 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$38.94 - $50.85 $3.56 Million - $4.65 Million	91,449 New	91,449 $3.73 Million
Q4 2020 Feb 11, 2021	SELL	$37.65 - $63.77 $1.96 Million - $3.32 Million	-52,126 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$52.76 - $74.49 $2.75 Million - $3.88 Million	52,126 New	52,126 $2.87 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.